7

Publikationen Prof. Dr. A. Rosenwald

Localized and Advanced Stage Follicular Lymphomas Differ in their Gene Expression Profiles. Blood. 2019 Oct 10. [Epub ahead of print]. JIF18: 16.601

37. Steen C.B., Leich E., Myklebust J.H., Lockmer S., Wise J.F., Wahlin B.E., Østenstad B.,

Liestøl K., Kimby E., Rosenwald A., Smeland E.B., Holte H., Lingjærde O.C., Brodtkorb M. A clinico-molecular predictor identifies follicular lymphoma patients at risk of early transformation after first-line immunotherapy. Haematologica. 2019 Mar 7. JIF18: 7.570

38. Stein R.G., Ebert S., Schlahsa L., Scholz C.J., Braun M., Hauck P., Horn E., Monoranu

C.M., Thiemann V.J., Wustrow M.P., Häusler S.F., Montalban Del Barrio I., Stueber T.N., Wölfl M., Dietl J., Rosenwald A., Diessner J.E., Wöckel A., Wischhusen J. Cognate Non-Lytic Interactions between CD8+ T cells and Breast Cancer Cells Induce Cancer Stem Cell-like Properties. Cancer Res. 2019 Jan 28. [Epub ahead of print]. JIF18: 8.378

39. Tanaka Y., Momose S., Tabayashi T., Sawada K., Yamashita T., Higashi M., Sagawa M.,

Tokuhira M., Rosenwald A., Kizaki M., Tamaru J.I. Abemaciclib, a CDK4/6 inhibitor, exerts preclinical activity against aggressive germinal center-derived B-cell lymphomas. Cancer Sci. 2019 Dec 17. [Epub ahead of print]. JIF18: 4.751

40. Wallaschek N., Niklas C., Pompaiah M., Wiegering A., Germer C.T., Kircher S.,

Brändlein S., Maurus K., Rosenwald A., Yan H.H.N., Leung S.Y., Bartfeld S. Establishing Pure Cancer Organoid Cultures: Identification, Selection and Verification of Cancer Phenotypes and Genotypes. J Mol Biol. 2019 May 29. JIF18: 5.067

2018

1. Appenzeller S., Gesierich A., Thiem A., Hufnagel A., Jessen C., Kneitz H., Regensburger M., Schmidt C., Zirkenbach V., Bischler T., Schilling B., Siedel C., Goebeler M.E., Houben R., Schrama D., Gehrig A., Rost S., Maurus K., Bargou R., Rosenwald A., Schartl M., Goebeler M., Meierjohann S. The identification of patient-specific mutations reveals dual pathway activation in most patients with melanoma and activated receptor tyrosine kinases in BRAF/NRAS wild-type melanomas. Cancer. 2018 Dec 18. doi: 10.1002/cncr.31843. [Epub ahead of print]

2. Aukema, S.M., Hoster, E., Rosenwald, A., Canoni, D., Delfau-Larue, M.H., Rymkiewicz,

G., Thorns, C., Hartmann, S., Kluin-Nelemans, H., Hermine, O., Dreyling, M., Klapper, W. Expression of TP53 is associated with the outcome of MCL independent of MIPI and Ki-67 in trials of the European MCL Network. Blood. 2018 Jan 25;131(4): S. 417-420

8

Publikationen Prof. Dr. A. Rosenwald

3. Barrio S., Stühmer T., Da-Viá M., Barrio-Garcia C., Lehners N., Besse A., Cuenca I.,

Garitano-Trojaola A., Fink S., Leich E., Chatterjee M., Driessen C., Martinez-Lopez J., Rosenwald A., Beckmann R., Bargou R.C., Braggio E., Stewart A.K., Raab M.S., Einsele H., Kortüm K.M. Spectrum and functional validation of PSMB5 mutations in multiple myeloma. Leukemia. 2018 Jul 19 [Epub ahead of print]

4. Chapuy B., Stewart C., Dunford A.J., Kim J., Kamburov A., Redd R.A., Lawrence M.S.,

Roemer M.G.M., Li A.J., Ziepert M., Staiger A.M., Wala J.A., Ducar M.D., Leshchiner I., Rheinbay E., Taylor-Weiner A., Coughlin C.A., Hess J.M., Pedamallu C.S., Livitz D., Rosebrock D., Rosenberg M., Tracy A.A., Horn H., van Hummelen P., Feldman A.L., Link B.K., Novak A.J., Cerhan J.R., Habermann T.M., Siebert R., Rosenwald A., Thorner A.R., Meyerson M.L., Golub T.R., Beroukhim R., Wulf G.G., Ott G., Rodig S.J., Monti S., Neuberg D.S., Loeffler M., Pfreundschuh M., Trümper L., Getz G., Shipp M.A. Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes. Nat Med. 2018 May;24(5):679-690.

5. Clot G., Jares P., Giné E., Navarro A., Royo C., Pinyol M., Martín-Garcia D., Demajo S.,

Espinet B., Salar A., Ferrer A., Muntañola A., Aymerich M., Rauert-Wunderlich H., Jaffe E.S., Connors J.M., Gascoyne R.D., Delabie J., López-Guillermo A., Ott G., Wright G.W., Staudt L.M., Rosenwald A., Scott D.W., Rimsza L.M., Beà S., Campo E. A new molecular assay and genomic complexity predict outcome in conventional and leukemic non-nodal mantle cell lymphoma. Blood. 2018 May 16.[Epub ahead of print]

6. Dugge R., Kreipe H., Rosenwald A., Lehmann U., Möller P., Barth T.F.E., Erlemann R..

Coincidence of lymphomatoid granulomatosis, chronic myelomonocytic leukemia, and anaplastic T cell lymphoma after methotrexate therapy for rheumatoid arthritis. Ann Hematol. 2018 Jul 7. [Epub ahead of print]

7. Elster D., Tollot M., Schlegelmilch K., Ori A., Rosenwald A., Sahai E., von Eyss B.

TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells. Nat Commun. 2018 Aug 6;9(1):3115.

8. Friedrichs B., Nickelsen M., Ziepert M., Altmann B., Haenel M., Viardot A., Schmidt C.,

Ruebe C., Loeffler M., Pfreundschuh M., Rosenwald A., Glass B., Lenz G., Schmitz N., German high-grade lymphoma Study Group. Doubling rituximab in high-risk patients with aggressive B-cell lymphoma -results of the DENSE-R-MegaCHOEP trial. Br J Haematol. 2018 Dec 5 [Epub ahead of print]

9. Frings V.G., Schäfer K., Strate A., Rosenwald A., Roth S., Kneitz H., Goebeler M.,

Geissinger E., Wobser M. Paraproteinaemia in Primary Cutaneous Marginal Zone Lymphoma. Acta Derm Venereol. 2018 Nov 5;98(10):956-962

9

Publikationen Prof. Dr. A. Rosenwald

10. Gröbner S.N., …Hummel M., Klapper W., Kostezka U., Lenze D., Möller P., Rosenwald A., Ott G., Szczepanowski M., Ammerpohl O., Aukema S.M., Binder V., Borkhardt A., Haake A., Hoell J.I., Leich E., Lichter P., López C., Nagel I., Pischimariov J., Radlwimmer B., Richter J… The landscape of genomic alterations across childhood cancers. Nature. 2018 Mar 15;555(7696):321-327.

11. Gröbner...Hummel M., Klapper W., Kostezka U., Lenze D., Möller P., Rosenwald A.,

Ott G., Szczepanowski M., Ammerpohl O., Aukema S.M., Binder V., Borkhardt A., Haake A., Hoell J.I., Leich E., Lichter P., López C., Nagel I., Pischimariov J., Radlwimmer B., Richter J., Rosenstiel P., Rosenwald A., Schilhabel M., Schreiber S., Vater I., Wagener R., Siebert ... Author Correction: The landscape of genomic alterations across childhood cancers. Nature. 2018 Jun 6. [Epub ahead of print]

12. Gutsch J., Werthmann P.G., Rosenwald A., Kienle G.S.

Complete Remission and Long-term Survival of a Patient with a Diffuse Large B-cell Lymphoma Under Viscum album Extracts After Resistance to R-CHOP: A Case Report. Anticancer Res. 2018 Sep;38(9):5363-5369

13. Hellmuth J.C., Louissaint A Jr., Szczepanowski M., Haebe S., Pastore A., Alig S., Staiger

A.M., Hartmann S., Kridel R., Ducar M.D., Koch P., Dreyling M., Hansmann M.L., Ott G., Rosenwald A., Gascoyne R.D., Weinstock D.M., Hiddemann W., Klapper W., Weigert O. Duodenal type and nodal follicular lymphoma differ by their immune microenvironment rather than their mutation profiles. Blood. 2018 Aug 20. [Epub ahead of print]

14. Holte H., Beiske K., Boyle M., Trøen G., Blaker Y.N., Myklebust J., Kvaløy S.,

Rosenwald A., Lingjaerde O.C., Rimsza L.M., Smeland E.B., Scott D.W., Kolstad A. The MCL35 gene expression proliferation assay predicts high-risk MCL patients in a Norwegian cohort of younger patients given intensive first line therapy. Br J Haematol. 2018 Aug 6. [Epub ahead of print]

15. Horn H., Kohler C., Witzig R., Kreuz M., Leich E., Klapper W., Hummel M., Loeffler M., Trümper L., Spang R., Rosenwald A., Ott G. Gene expression profiling reveals a close relationship between follicular lymphoma grade 3A and 3B, but distinct profiles of follicular lymphoma grade 1 and 2. Haematologica. 2018 Mar 22 [Epub ahead of print]

16. Kircher S., Stolzenburg A., Kortuem K.M., Kircher M., Da Via M., Samnick S., Buck A.,

Einsele H., Rosenwald A., Lapa C. Hexokinase-2 Expression in MET-positive FDG-negative Multiple Myeloma. J Nucl Med. 2018 Nov 2. [Epub ahead of print]

17. Klapper W., Fend F., Feller A., Hansmann M.L., Möller P., Stein H., Rosenwald A., Ott

G.

10

Publikationen Prof. Dr. A. Rosenwald

[Aggressive B-cell lymphomas : Recommendations from the German Panel of Reference Pathologists in the Competence Network on Malignant Lymphomas on diagnostic procedures according to the current WHO classification, update 2017]. Pathologe. 2018 Apr 17. [Epub ahead of print]

18. Lapa, C., Lückerath, K., Kircher, S., Hänscheid, H., Grigoleit, G., Rosenwald, A.,

Stolzenburg, A., Kropf, S., Einsele, H., Wester, H., Buck, A., Kortüm, K., Schirbel A. Potential influence of concomitant chemotherapy on CXCR4 expression in receptor directed endoradiotherapy. Br J Haematol. 2018 Jan. [Epub ahead of print]

19. Lapa C., Schreder M., Lückerath K., Samnick S., Rudelius M., Buck A.K., Kortüm K.M.,

Einsele H., Rosenwald A., Knop S. [11 C]Methionine emerges as a new biomarker for tracking active myeloma lesions. Br J Haematol. 2018 Jun;181(5):701-703.

20. Laufs, V., Altieri, B., Sbiera, S., Kircher, S., Steinhauer, S., Beuschlein, F., Quinkler, M.,

Willenberg, H.S., Rosenwald, A., Fassnacht. M., Ronchi, C.L.. ERCC1 as predictive biomarker to platinum-based chemotherapy in adrenocortical carcinomas. Eur J Endocrinol. 2018 Feb; 178(2): S. 183-190

21. Lippert J., Appenzeller S., Liang R., Sbiera S., Kircher S., Altieri B., Nanda I., Weigand

I., Gehrig A., Steinhauer S., Riemens R.J.M., Rosenwald A., Müller C.R., Kroiss M., Rost S., Fassnacht M., Ronchi C.L. Targeted molecular analysis in adrenocortical carcinomas: a strategy towards improved personalized prognostication. J Clin Endocrinol Metab. 2018 Aug 2. [Epub ahead of print]

22. Martín-Garcia D., Navarro A., Valdés-Mas R., Clot G., Gutiérrez-Abril J., Prieto M.,

Ribera-Cortada I., Woroniecka R., Rymkiewicz G., Bens S., de Leval L., Rosenwald A., Ferry J.A., Hsi E.D., Fu K., Delabie J., Weisenburger D., de Jong D., Climent F., O'Connor S.J., Swerdlow S.H., Torrents D., Beltran S., Espinet B., González-Farré B., Veloza L., Costa D., Matutes E., Siebert R., Ott G., Quintanilla-Martinez L., Jaffe E., López-Otín C., Salaverria I., Puente X.S., Campo E., Beà S. CCND2 and CCND3 hijack immunoglobulin light chain enhancers in cyclin D1-negative mantle cell lymphoma. Blood. 2018 Dec 11 [Epub ahead of print]

23. Maurus K., Appenzeller S., Roth S., Kuper J., Rost S., Meierjohann S., Arampatzi P.,

Goebeler M., Rosenwald A., Geissinger E., Wobser M.. Panel Sequencing Shows Recurrent Genetic FAS Alterations in Primary Cutaneous Marginal Zone Lymphoma. J Invest Dermatol. 2018 Jul;138(7):1573-1581.

24. Meir J., Hartmann E., Eckstein M.T., Guiducci E., Kirchner F., Rosenwald A.,

LeibundGut-Landmann S., Christian Pérez J. Identification of Candida albicans regulatory genes governing mucosal infection.

11

Publikationen Prof. Dr. A. Rosenwald

Cell Microbiol. 2018 Aug;20 (8)

25. Mendeville M., Roemer M.G.M., van den Hout M.F.C.M., Los-de Vries G.T., Bladergroen R., Stathi P., Hijmering N.J., Rosenwald A., Ylstra B., de Jong D. Aggressive genomic features in clinically indolent primary HHV8-negative effusion-based lymphoma. Blood. 2018 Dec 3 [Epub ahead of print]

26. Mottok, A., Jurinovic, V., Farinha, P., Rosenwald, A., Leich, E., Ott, G., Horn, H.,

Klapper, W., Boesl, M., Hiddemann, W., Steidl, C., Connors, J.M., Sehn, L.H., Gascoyne, R.D., Hoster, E., Weigert, O., Kridel, R. FOXP1 expression is a prognostic biomarker in follicular lymphoma treated with rituximab and chemotherapy. Blood. 2018 Jan; 131(2): S. 226-235

27. Mottok A., Rosenwald A.

Methotrexate-induced lymphoproliferative disorders: regression matters. Leuk Lymphoma. 2018 Feb 22:1-3. [Epub ahead of print]

28. Mottok A., Wright G., Rosenwald A., Ott G., Ramsower C., Campo E., Braziel R.M.,

Delabie J., Weisenburger D.D., Song J.Y., Chan W.C., Cook J.R., Fu K., Greiner T., Smeland E., Holte H., Savage K.J., Glinsmann-Gibson B.J., Gascoyne R.D., Staudt L.M., Jaffe E.S., Connors J.M., Scott D.W., Steidl C., Molecular classification of primary mediastinal large B-cell lymphoma using routinely available tissue specimens. Blood. 2018 Sep 26.Epub ahead of print

29. Mutzbauer G., Maurus K., Buszello C., Pischimarov J., Roth S., Rosenwald A., Chott A.,

Geissinger E. SYK expression in monomorphic epitheliotropic intestinal T-cell lymphoma. Mod Pathol. 2018 Mar;31(3):505-516.

30. Ohgami R.S., Rosenwald A., Bagg A.

Next-Generation Sequencing for Lymphomas: Perfecting a Pipeline for Personalized Pathobiologic and Prognostic Predictions. J Mol Diagn. 2018 Mar;20(2):163-165.

31. Olmes D.G., Metz I., Lee D.H., Rosenwald A., Doerfler A., Brück W., Linker R.A.

CLIPPERS with longitudinally extensive transverse myelitis: Role of T versus B cells. J Neurol Sci. 2018 Feb; 385:96-98.

32. Ott G., Klapper W., Feller A.C., Hansmann M.L., Möller P., Stein H., Rosenwald A.,

Fend F. [Revised version of the 4th edition of the WHO classification of malignant lymphomas : What is new?] Pathologe. 2018 Jul 17. [Epub ahead of print]

12

Publikationen Prof. Dr. A. Rosenwald

33. Paul U., Richter J., Stuhlmann-Laiesz C., Kreuz M., Nagel I., Horn H., Staiger A.M., Aukema S.M., Hummel M., Ott G., Spang R., Rosenwald A., Feller A.C., Cogliatti S., Stein H., Hansmann M.L., Moller P., Szczepanowski M., Burkhardt B., Pfreundschuh M., Schmitz N., Loeffler M., Trümper L., Siebert R., Klapper W. Advanced patient age at diagnosis of diffuse large B-cell lymphoma is associated with molecular characteristics including ABC-subtype and high expression of MYC. Leuk Lymphoma. 2018 May;59(5):1213-1221.

34. Phelan J.D., Young R.M., Webster D.E., Roulland S., Wright G.W., Kasbekar M., Shaffer

A.L., Ceribelli M., Wang J.Q., Schmitz R., Nakagawa M., Bachy E., Huang D.W., Ji Y., Chen L., Yang Y., Zhao H., Yu X., Xu W., Palisoc M.M., Valadez R.R., Davies-Hill T., Wilson W.H., Chan W.C., Jaffe E.S., Gascoyne R.D., Campo E., Rosenwald A., Ott G., Delabie J., Rimsza L.M., Rodriguez F.J., Estephan F., Holdhoff M., Kruhlak M.J., Hewitt S.M., Thomas C.J., Pittaluga S., Oellerich T., Staudt L.M. A multiprotein supercomplex controlling oncogenic signalling in lymphoma. Nature. 2018 Jun 20. [Epub ahead of print]

35. Rauert-Wunderlich, H., Rudelius, M., Berberich, I., Rosenwald, A.

CD40L mediated alternative NFκB-signaling induces resistance to BCR-inhibitors in patients with mantle cell lymphoma. Cell Death Dis. 2018 Jan.; 9(2)

36. Rauert-Wunderlich H., Mottok A., Scott D.W., Rimsza L.M., Ott G., Klapper W.,

Unterhalt M., Kluin-Nelemans H.C., Hermine O., Hartmann S., Thorns C., Rymkiewicz G., Holte H., Dreyling M., Hoster E., Rosenwald A. Validation of the MCL35 gene expression proliferation assay in randomized trials of the European Mantle Cell Lymphoma Network. Br J Haematol. 2018 Aug 10. [Epub ahead of print]

37. Reinke S., Richter J., Fend F., Feller A., Hansmann M.L., Hüttl K., Oschlies I., Ott G.,

Möller P., Rosenwald A., Stein H., Altenbuchinger M., Spang R., Klapper W. Round-robin test for the cell-of-origin classification of diffuse large B-cell lymphoma-a feasibility study using full slide staining. Virchows Arch. 2018 May 5. [Epub ahead of print]

38. Ritter J., Zimmermann K., Jöhrens K., Mende S., Seegebarth A., Siegmund B., Hennig

S., Todorova K., Rosenwald A., Daum S., Hummel M., Schumann M. T-cell repertoires in refractory coeliac disease. Gut. 2018 Apr;67(4):644-653.

39. Roisman A., Castellano G., Navarro A., Gonzalez-Farre B., Pérez-Galan P., Esteve-

Codina A., Dabad M., Heath S., Gut M., Bosio M., Bellot P., Salembier P., Oliveras A., Slavutsky I., Magnano L., Horn H., Rosenwald A., Ott G., Aymerich M., López-Guillermo A., Jares P., Martín-Subero J.I., Campo E., Hernández L. Differential expression of long non-coding RNAs are related to proliferation and histological diversity in follicular lymphomas. Br J Haematol. 2018 Nov 22. doi: 10.1111/bjh.15656. [Epub ahead of print]

13

Publikationen Prof. Dr. A. Rosenwald

40. Rudelius, M., Rosenfeldt, M.T., Leich, E., Rauert-Wunderlich, H., Solimando, A.G., Beilhack, A., Ott, G., Rosenwald, A. Inhibition of focal adhesion kinase overcomes resistance of mantle cell lymphoma to ibrutinib in the bone marrow microenvironment Haematologica. 2018 Jan; 103(1): S. 116-125

41. Schmitz R., Wright G.W., Huang D.W., Johnson C.A, Phelan J.D., Wang J.Q., Roulland

S., Kasbekar M., Chan W.C., Jaffe E.S., Gascoyne R.D., Connors J.M., Campo E., Lopez-Guillermo A., Rosenwald A., … Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma. N Engl J Med. 2018 Apr 12;378(15):1396-1407.

42. Scott D.W., King R.L., Staiger A.M., Ben-Neriah S., Jiang A., Horn H., Mottok A.,

Farinha P., Slack G.W., Ennishi D., Schmitz N., Pfreundschuh M., Nowakowski G.S., Kahl B.S., Connors J.M., Gascoyne R., Ott G., Macon W.R., Rosenwald A. High grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements with diffuse large B-cell lymphoma morphology. Blood. 2018 Feb 23.[Epub ahead of print]

43. Solimando A.G., Brandl A., Mattenheimer K., Graf C., Ritz M., Ruckdeschel A.,

Stühmer T., Mokhtari Z., Rudelius M., Dotterweich J., Bittrich M., Desantis V., Ebert R., Trerotoli P., Frassanito M.A., Rosenwald A., Vacca A., Einsele H., Jakob F., Beilhack A. JAM-A as a prognostic factor and new therapeutic target in multiple myeloma. Leukemia. 2018 Mar;32(3):736-743.

44. Thurner L., Preuss K.D., Bewarder M., Kemele M., Fadle N., Regitz E., Altmeyer S.,

Schormann C., Poeschel V., Ziepert M., Walter S., Roth P., Weller M., Szczepanowski M., Klapper W., Monoranu C., Rosenwald A., Möller P., Hartmann S., Hansmann M.L., Mackensen A., Schäfer H., Schorb E., Illerhaus G., Buslei R., Bohle R.M., Stilgenbauer S., Kim Y.J., Pfreundschuh M. Hyper N-glycosylated SAMD14 and neurabin-I as driver CNS autoantigens of PCNSL. Blood. 2018 Sep 24.[Epub ahead of print]

45. Wegert J., Vokuhl C., Collord G., Del Castillo Velasco-Herrera M., Farndon S.J., Guzzo

C., Jorgensen M., Anderson J., Slater O., Duncan C., Bausenwein S., Streitenberger H., Ziegler B., Furtwängler R., Graf N., Stratton M.R., Campbell P.J., Jones D.T., Koelsche C., Pfister S.M., Mifsud W., Sebire N., Sparber-Sauer M., Koscielniak E., Rosenwald A., Gessler M., Behjati S. Recurrent intragenic rearrangements of EGFR and BRAF in soft tissue tumors of infants. Nat Commun. 2018 Jun 18;9(1):2378.

46. Zamò A., Pischimarov J., Schlesner M., Rosenstiel P., Bomben R., Horn H., Grieb T.,

Nedeva T., López C.9, Haake A., Richter J., Trümper L., Lawerenz C., Klapper W., Möller P., Hummel M., Lenze D., Szczepanowski M., Flossbach L., Schreder M., Gattei V., Ott G., Siebert R., Rosenwald A., Leich E.

14

Publikationen Prof. Dr. A. Rosenwald

Differences between BCL2-break positive and negative follicular lymphoma unraveled by whole-exome sequencing. Leukemia. 2018 Mar;32(3):685-693.

47. Zamò, A., Pischimarov, J., Horn, H., Ott, G., Rosenwald, A., Leich, E.

The exomic landscape of t(14;18)-negative diffuse follicular lymphoma with 1p36 deletion. Br J Haematol. 2018 Feb; 180(3): S. 391-394

2017

1. Altieri B, Sbiera S, Della Casa S, Weigand I, Wild V, Steinhauer S, Fadda G, Kocot A, Bekteshi M, Mambretti EM, Rosenwald A, Pontecorvi A, Fassnacht M, Ronchi CL Livin/BIRC7 expression as malignancy marker in adrenocortical tumors Oncotarget. 2017;8:9323-9338

2. Aukema SM, Hoster E, Rosenwald A, Canoni D, Delfau-Larue MH, Rymkiewicz G,

Thorns C, Hartmann S, Kluin-Nelemans H, Hermine O, Dreyling M, Klapper W Expression of TP53 is associated with ourtcome of MCL independent of MIPI and Ki-67 in trials of the European-MCL Network Blood. 2017 Dec 1 (epub ahead of print)

3. Bouska A, Bi C, Lone W, Zhang W, Kedwaii A, Heavican T, Lachel CM, Yu J, Ferro R,

Eldorghamy N, Greiner TC, Vose J, Weisenburger DD, Gascyone RD, Rosenwald A, Ott G, Campo E, Rimsza LM, Jaffe ES, Braziel RM, Siebert R, Miles RR, Dave S, Reddy A, Delabie J, Staudt LM, Song JY, McKeithan TW, Fu K, Green M, Chan WC, Iqbal J Adult high grade B-cell lyphoma with Burkitt lymphoma signature: genomic features and potential therapeutic targets Blood. 2017;130:1819-1832

4. Bouska A, Zhang W, Gong Q, Iqbal J, Scuto A, Vose J, Ludwigsen M, Fu K,

Weisenburger DD, Greiner TC, Gascoyne RD, Rosenwald A, Ott G, Campo E, Rimsza LM, Delabie J, Jaffe ES, Braziel RM, Connors JM, Wu CI, Staudt LM, D’Amore F, McKeithan TW, Chan C Combined copy number and mutation analysis identifies oncogenic pathways associated with transformation of follicular lymphoma Leukemia. 2017;31:83-91

5. Dai B, Grau M, Juilland M, Klener P, Höring E, Molinsky J, Schimmack G, Aukema SM,

Hoster E, Vogt N, Satiger AM, Erdmann T, Xu, W, Erdmann K, Dzyube N, Madle H, Berdel WE, Trneny M, Dreyling M, Jöhrens K, Lenz P, Rosenwald A, Siebert R, Tzankov A, Klapper W, Anagnostopoulus I, Krappmann D, Ott G, Thome M, Lenz G B-cell receptor-driven MALT1 activity regulates MYC signaling in mantle cell lymphoma Blood. 2017;129:333-346

15

Publikationen Prof. Dr. A. Rosenwald

6. de Leval L, Copie-Bergmann C, Rosenwald A, Rimsza L, Pittaluga S, Bisig B, Dirnhofer

S, Facchetti F, Pileri S, Fend F, Wotherspoon A B cell lymphomas with discordance between pathological features and clinical behaviour Virchows Arch. 2017; 471:439-451

7. Duell J, Dittrich M, Bedke T, Mueller T, Eisele F, Rosenwald A, Rasche L, Hartmann E,

Dandekar T, Einsele H, Topp MS Frequency of regulatory T cells determines the outcome of the T cell engaging antibody blinatumomab in patients with B precursor ALL Leukemia. 2017;31:2181-2190

8. Facchetti F, Pileri SA, Lorenzi L, Tabanelli V, Rimsza L, Pittaluga S, Dirnhofer S, Copie-

Bergman C, de Leval L, Rosenwald A, Wotherspoon A, Fend F Histiocytic and dendritic cell neoplasms: what have we learnt by studying 67 cases Virchows Arch. 2017;471:467-489

9. Fellbaum C, Kircher S, Oehler U, Blessing R, Rosenwald A

Blastäres Tumorgewebe in Halslymphknoten mit Expression plazentaalkalischer Phosphatase Pathologe. 2017;38:112-116

10. Frings VG, Roth S, Riedmiller AL, Schäfer K, Goebeler M, Rosenwald A, Geissinger E,

Wobser M Primary cutaneous T-cell lymphoma with abberant expression of CD20 Acta Derm Venereol. 2017;97:534-536

11. Gascoyne RD, Campo E, Jaffe ES, Chan WC, Chan JKC, Rosenwald A, Stein H,

Swerdlow SH Diffuse large B-cell lymphoma, NOS In: WHO classification of tumours of haematopoietic and lymphoid tissues. Ed. by Steven H. Swerdlow, Elias Campo, Nancy Lee Harris et al. Revised 4th ed. Lyon: International Agency on Cancer, 2017. pp. 263-265

12. Glass B, Dohm AJ, Truemper LH, Pfreundschuh M, Bleckmann A, Wulf GG, Rosenwald

A, Ziepert M, Schmitz N; German High-grade Lymphoma Study Group (DSHNHL) Refractory or relapsed aggressive B-cell lymphoma failing(R)-CHOP: an analysis of patients treated on the RICOVER-60 trial Ann Oncol. 2017;28:3058-3064

13. Henning JEK, Deutschbein T, Altieri B, Steinhauer S, Kircher S, Sbiera S, Wild V,

Schlötelburg W, Kroiss M, Perotti P, Rosenwald A, Berruti A, Fassnacht M, Ronchi CL Gemcitabine-based chemotherapy in adrenocortical carcinoma: a multicentric study on efficiacy and predictive factors J Clin Endocrinol Metab. 2017;102:4323-4332

14. Iltzsche F, Simon K, Stopp S, Pattschull G, Francke S, Wolter P, Hauser S, Murphy DJ,

Garcia P, Rosenwald A, Gaubatz S

16

Publikationen Prof. Dr. A. Rosenwald

An important role for Myb-MuvB and its target gene KIF23 in a mouse model of lung adenocarcinoma Oncogene. 2017;36:110-121

15. Kreft A, Krümpelmann K, Rosenwald A, Hollemann D, Wagner-Drouet EM Dermatopathic lymphadenopathy with Langerhans cell chimerism in graft-versus-host disease of the skin Eur J Haematol. 2017;99:582-585

16. Kühnl A, Cunningham D, Counsell N, Hawkes EA, Qian W, Smith P, Chadwick N, Lawrie

A, Mouncey P, Jack A, Pocock A, Ardeshna KM, Radford J, McMillan A, Davies J, Turner T, Kruger A, Johnson P, Gambell J, Rosenwald A, Ott G, Horn H, Ziepert M, Pfreundschuh M, Linch D Outcome of elderly patients with diffuse large B-cell lymphoma treated with R-CHOP: results from the UK NCRI R-CHOP14v21 trial with combined analysis of molecular characteristics with the DSHNHL RICOVER-60 trial Ann Oncol. 2017;28:1540-1546

17. Lapa C, Schreder M, Lückerath K, Samnick S, Rudelius M, Buck AK, Kortüm KM, Einsele

H, Rosenwald A, Knop S [11 C] Methionine emerges as a new biomarker for tracking active myeloma lesions Br J Haematol. 2017 May 3 (epub ahead of print)

18. Lapa C, Kircher S, Schirbel A, Rosenwald A, Kropf S, Pelzert T, Walles T, Buck AK,

Weber WA, Wester HJ, Herrmann K, Lückerath K Targeting CXCR4 with [68Ga]Pentixafor: a suitable theranostic approach in pleural mesothelioma Oncotarget. 2017;8;96732-96737

19. Laufs V, Altieri B, Sbiera S, Kircher S, Steinhauer S, Beuschlein F, Quinkler M,

Willenberg HS, Rosenwald A, Fassnacht M, Ronchi CL ERCC1 as predictive biomarker to platinum-based chemotherappy in adrenocortical Carcinomas Eur J Endocrinol. 2017 Nov 29 (epub ahead of print)

20. Mottok A, Jurinovic V, Farinha P, Rosenwald A, Leich E, Ott G, Horn H, Klapper W,

Boesl M, Hiddemann W, Steidl C, Connors JM, Sehn LH, Gascoyne RD, Hoster E, Weigert O, Kridel R FOXP1 eexpression is a prognostic biomarker in follicular lymphoma treated with rituximab-containing regiments Blood. 2017 Nov 9 (epub ahead of print)

21. Müller E, Bauer S, Stühmer T, Mottok A, Scholz CJ, Steinbrunn T, Brünnert D, Brandl

A, Schraud H, Kreßmann S, Beilhack A, Rosenwald A, Bargou RC, Chatterjee M Pan-Raf co-operates with PI3K-dependent signalling and critically contributes to myeloma cell survival independently of mutated RAS Leukemia. 2017;31:922-933

17

Publikationen Prof. Dr. A. Rosenwald

22. Mutzbauer G, Maurus K, Buszello C, Pischimarov J, Roth S, Rosenwald A, Chott A,

Geissinger E SYL expression in monomorphic epitheliotropic intestinal T-cell lymphoma Mod Pathol. 2017 Oct. 20 (epub ahead of print)

23. Paul U, Richter J, Stuhlmann-Laiesz C, Nagel I, Horn H, Staiger AM, Aukema SM,

Hummel M, Ott G, Spang R, Rosenwald A, Feller AC, Cogliatti S, Stein H, Hansmann ML, Moeller P, Szczepanowski M, Burkhardt B, Pfreundschuh M, Schmitz N, Loeffler M, Trümper L, Siebert R, Klapper W Advanced patient age at diagnosis of diffuse large B-cell lymphoma is associated with molecular characteristics including ABC-subtype and high expression of MYC Leuk Lymphoma. 2017 Aug 25:1-9 (epub ahead of print)

24. Rimsza L, Pittaluga S, Dirnhofer S, Copie-Bergman C, deLeval L, Facchetti F, Pileri S,

Rosenwald A, Wotherspoon A, Fend F The clinicopathologic spectrum of mature aggressive B cell lymphomas Virchows Arch. 2017;471:453-466

25. Ritter J, Zimmermann K, Jöhrens K, Mende S, Seegebarth A, Siegmund B, Hennig S,

Todorova K, Rosenwald A, Daum S, Hummel M, Schuhmann M T-cell repertoires in refractory coeliac disease Gut. 2017 Feb 10 (epub ahead of print)

26. Röhrig F, Vorlová S, Hoffmann H, Wartenberg M, Escorcia FE, Keller S, Tenspolde M,

Weigand I, Gätzner S, Manova K, Penack O, Scheinberg DA, Rosenwald A, Ergün S, Granot Z, Henke E VEG-ablation therapy reduces drug delivers and therapeutic response in ECM-dense tumors Oncogene. 2017;36:1-12

27. Rohde M, Bonn BR, Zimmermann M, Lange J, Möricke A, Klapper W, Oschlies I,

Szczepanowski M, Nagel I, Schrappe M, Loeffler M, Siebert R, Reiter A, Burkhardt B; ICGC-MMML-Seq; MMML-MYC-SYS Collaborators: Richter G, … Rosenwald A, … Leich E, … Pischimarov J, …Löffler-Wirth Relevance of ID3-TCF3-CCND3 pathway mutations in pediatric aggressive B-cell lymphoma treated according to the NHL-BFM protocols Haematologica. 2017;102:1091-1098

28. Rudelius M, Brehm K, Poelcher M, Spinner C, Rosenwald A, da Costa CP

First case of human peritoneal cysticercosis mimicking peritoneal carcinosis: necessity of laparoscopy and histologic assessment for the correct diagnosis JMM Case Rep. 2017; 4:e005097

29. Rudelius M, Rosenfeldt MT, Leich E, Rauert-Wunderlich H, Solimando AG, Beilhack A,

Ott G, Rosenwald A Inhibition of focal adhesion kinase overcomes resistance of mantle cell lymphoma to ibrutinib in the bone marrow microenvironment

18

Publikationen Prof. Dr. A. Rosenwald

Haematologica Oct. 27 (epub ahead of print)

30. Said J, Cesarman E, Rosenwald A, Harris NL Lymphomas associated with HIV infection In: WHO classification of tumours of haematopoietic and lymphoid tissues. Ed. by Steven H. Swerdlow, Elias Campo, Nancy Lee Harris et al. Revised 4th ed. Lyon: International Agency on Cancer, 2017. pp. 263-265

31. Schmidt J, Ramis-Zaldivar JE, Nadeu F, Gonzalez-farre B, Navarro A, Egan C, Montes-

Mojarro IA, Marafioti T, Cabeçadas J, van der Walt J, Dojconov S, Rosenwald A, Ott G, Bonzheim I, Fend F, Campo E, Jaffe ES, Salaverria I, Quintanilla-Martinez L Mutations of MAP2K1 are frequent in pediatric-type follicular lymphoma and result in ERK pathway activation Blood. 2017;130:323-327

32. Scott DW, Abrisqueta P, Wright GW, Slack GW, Mottok A, Villa D, Jares R, Rauert-

Wunderlich H, Royo C, Clot G, Pinyol M, Boyle M, Chan FC, Braziel RM, Chan WC, Weisenburger DD, Cook JR, Greiner TC, Fu K, Ott G, Delabie J, Smeland EB, Holte H, Jaffe ES, Steidl C, Connors JM, Gascoyne RD, Rosenwald A, Staudt LM, Campo E., Rimsza LM; Lymphoma/Leukemia Molecular Profiling Project New molecular assay for the proliferation signature in mantle cell lymphoma applicable to formalin-fixed paraffin-embedded biopsies J Clin Oncol. 2017;35:1668-1677

33. Solimando AG, Brandl A, Mattenheimer K, Graf C, Ritz M, Ruckdeschel A, Stühmer T,

Mokhtari Z, Rudelius M, Dotterweich J, Bittrich M, Desantis V, Ebert R, Trerotoli P, Frassanito MA, Rosenwald A, Vacca A, Einsele H, Jakob F, Beilhack A JAM-A as a prognostic factor and new therapeutic target in multiple myeloma Leukemia. 2017 Sep 28 (epub ahead of print)

34. Staiger AM, Duppel J, Dengler MA, van der Kuip H, Vöhringer MC, Aulitzky WE,

Rosenwald A, Ott G, Horn H An analysis of the role of follicular lymphoma-associated fibroblasts to promote tumor cell viability following drug-induced apoptosis Leuk Lymphoma. 2017;58:1922-1930

35. Staiger AM, Ziepert M, Horn H, Scott DW, Barth TFE, Bernd HW, Feller AC, Klapper W,

Szczepanowski M, Hummel M, Stein H, Lenze D, Hansmann ML, Hartmann S, Möller P, Cogliatti S, Lenz G, Trümper L, Löffler M, Schmitz N, Pfreundschuh M, Rosenwald A, Ott G; German High-Grade Lymphoma Study Group. Clinical impact of the cell-of-origin classification an the MYC/BCL2 dual expresser status in diffuse large B-cell lymphoma treated with prospective clinical trials of the germ Hifh-Grade Non-Hodgkin’s Lymphoma Study Group J Clin Oncol 2017;58:1922-1930

36. Stevens WBC, Mendeville M, Redd R, Clar AJ, Bladergrœn R, Calaminici M, Rosenwald

A, Hoster E, Hiddemann W, Gaulard P, Xerri L, Salles G, Klapper W, Pfreundschuh M, Jack A, Gascoyne RD, Natkunam Y, Advani R, Kimby E, Sander B, Sehn L, Hagenbeek A, Raemaekers J, Gribben J. Kersten MJ, Ylstra B, Weiler E, de Jong D

19

Publikationen Prof. Dr. A. Rosenwald

Prognostic relevance of CD163 and CD8 combined with EZH2 and gain of chromosome 18 in follicular lymphoma: a study by the Lunenburg Lymphoma Biomarker Consortium Haematologica. 2017;102:1413-1423

37. Toksoy A, Strifler S, Benoit S, Grigoleit GU, Knop S, Mielke S, Buder-Bakhaya K, Roth S,

Goebeler M, Rosenwald A, Geissinger E, Wobser M Facial swelling and Hydroa Vacciniform-like skin lesions in Epstein-Barr virus-associated T-cell lymphoproliferation with subsequent development of lymphoma Acta Derm Venereol. 2017;97:379-380

38. Walter R, Pan KT, Doebele C, Comoglio F, Tomska K, Bohnenberger H, Young RM,

Jacobs L, Keller U, Bonig H, Engelke M, Rosenwald A, Urlaub H, Staudt LM, Serve H, Zenz T, Oellerich T HSP90 promotes Burkitt lymphoma cell survival by maintaining tonic B cell receptor signaling Blood. 2017;129:598-608

39. Wobser M, Maurus K, Roth S, Appenzeller S, Weyandt G, Goebeler M, Rosenwald A,

Geissinger E Myeloid differentiation primary response 88 mutations in a distinct type of cutaneous marginal-zone lymphoma with a nonclass switched immunoglobulin M immunophenotype Br J Dermatol. 2017;177:564-566

40. Zamò A, Pischimarov J, Schlesner M, Rosenstiel P, Bomben R, Horn H, Grieb T,

Nedeva T, López C, Haake A, Richter J, Trümper L, Lawerenz C, Klapper W, Möller P, Hummel M, Lenze D, Szczepanowski M, Flossbach L, Schreder M, Gattei V, Ott G, Siebert R, Rosenwald A, Leich E Differences between BCL2-break positive and negative follicular lymphoma unraveled by whole exome sequencing Leukemia. 2017 Aug 21 (epub ahead of print)

41. Zamò A, Pischimarov J, Horn H, Ott G, Rosenwald A, Leich E.

The exomic landscape of t(14;18)-negative diffuse follicular lymphoma with 1p36 deletion Br J Haematol. 2017 Nov 28 (epub ahead of print)

42. Zenz T, Kreuz M, Fuge M, Klapper W, Horn H, Staiger AM, Winter D, Helfrich H,

Huellein J, Hansmann ML, Stein H, Feller A, Möller P, Schmitz N, Trümper L, Loeffler M, Siebert R, Rosenwald A, Ott G, Pfreundschuh M, Stilgenbauer S; German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL) TP53 mutation and survival in aggressive B cell lymphoma Int J Cancer. 2017;141:1381-1388

20

Publikationen Prof. Dr. A. Rosenwald

2016

1. Almanzar G, Klein M, Schmalzing M, Hilligardt D, El Hajj N, Kneitz H, Wild V, Rosenwald A, Benoit S, Hamm H, Tony HP, Haaf T, Giebeler M, Prelog M Disease manifestation and inflammatory activity as modulators of Th17/Treg balance and RORC/FoxP3 methylation in systemic sclerosis Int Arch Allergy Immunol. 2016;171:141-154

2. Brisam M, Rauthe S, Hartmann S, Linz C, Brands RC, Kübler AC, Rosenwald A, Müller-

Richter DU Expression of MAGE-A1-A12 subgroups in the invasive tumor front and tumor center in oral squamous cell carcinoma Oncol Rep. 2016;35:1979-1986

3. Dietl S, Schwinn S, Dietl S, Riedel S, Deinlein F, Rutkowski S, von Bueren AO, Krauss J,

Schweitzer T, Vince GH, Picard D, Eyrich M, Rosenwald A, Ramaswamy V, Taylor MD, Remke M, Monoranu CM, Beilhack A, Schlegel PG, Wölfl M MB3W1 in an orthotopic xenograft model for anaplastic medulloblastoma displaying cancer stem cell- and Group 3-properties BMC Cancer. 2016;16:115

4. Engel K, Rudelius M, Slawska J, Jacobs L, Ahangarian Abhari B, Altmann B, Kurutz J,

Rathakrishnan A, Fernández-Sáiz V, Brunner A, Targosz BS, Loewecke F, Gloeckner CJ, Ueffing M, Fulda S, Pfreundschuh M, Trümper L, Klapper W, Keller U, Jost PJ, Rosenwald A, Peschel C, Bassermann F USP9X stabilizes XIAP to regulate mitotic cell death and chemoresistance in aggressive B-cell lymphoma EMBO Mol Med. 2016;8:851-862

5. Engert A, Balduini C, Brand A, Coiffier B, Cordonnier C, Döhner H, Duyvené de Wit T,

Eichinger S, Fibbe W, Green T, de Haas F, Iolascon A, Jaffredo T, Rodeghiero F, Salles G, Schuringa JJ, and the other authors of the EHARoadmap for European Hematology Research: … Rosenwald A … The European Hematology Association Roadmap for European Hematology Research: a consensus document Haematologica. 2016;101:115-208

6. Hartmann EM, Rudelius M, Burger JA, Rosenwald A

CCL3 chemokine expression by chronic lymphocytic leukemia cells orchestrates the composition of the microenvironment in lymph node infiltrates Leuk Lymphoma. 2016;57:221-232

7. Hartmann S, Brisam M, Rauthe S, Driemel O, Brands RC, Rosenwald A, Kübler AC, Müller-Richter UD

21

Publikationen Prof. Dr. A. Rosenwald

Contrary melanoma-associated antigen-A expression at the tumor front and center: a comparative analysis of stage I and IV head and neck squamous cell carcinoma Oncol Lett. 2016;12:2942-2947

8. Hezaveh K, Kloetgen A, Bernhart SH, Mahapatra KD, Lenze D, Richter J, Haake A,

Bermann AK, Brors B, Burkhardt B, Claviez A, Drexler H G, Eils R, Haas S, Hoffmann S., Karsch D, Klapper W, Kleinhenz K, Korbel J, Kretzmer H, Kreuz M, Küppers R, Lawerenz C, Leich E, Loeffler M, Mantovani-Loeffler L, López C, McHardy AC, Möller P, Rohde M, Rosenstiel P, Rosenwald A, Schilhabel M, Schlesner M, Scholz I, Stadler PF, Stilgenbauer S., Sungalee S, Szczepanowski M, Trümper L, Weniger MA, Siebert R, Borkhardt A, Hummel M, Hoell JI Alterations of miRNAs and miRNA-regulated mRNA expression in GC B cell lymphomas determined by integrative sequencing analysis Haematologica. 2016;101:1380-1389

9. Hoster E, Rosenwald A, Berger F, Bernd HW, Hartmann S, Loddenkemper C, BarthTF,

Brousse N, Pileri S, Rymkiewicz G, Kodet R, Stilgenbauer S, Forstpointner R, Thieblemont C, Hallek M, Coiffier B, Vehling-Kaiser U, Bouabdallah R, Kanz L, Pfreundschuh M, Schmidt C, Ribrag V, Hiddemann W, Unterhalt M, Kluin-Nelemans JC, Hermine O, Dreyling MH, Klapper W Prognostic value of Ki-67 index, cytology, and growth pattern in mantle-cell lymphoma: results from randomized trials of the European Mantle Cell Lymphoma Network J Clin Oncol. 2016;34:1396-1394

10. Jurinovic V, Kridel R, Staiger AM, Szczepanowski M, Horn H, Dreyling MH, Rosenwald

A, Ott G, Klapper W, Zelenetz AD, Barr PM, Friedberg JW, Ansell S, Sehn LH, Connors JM, Gascoyne RD, Hiddemann W, Unterhalt M, Weinstock DM, Weigert O Clinicogenetic risk models predict early progression of follicular lymphoma after first-line immunochemotherapy Blood. 2016;128:1112-1120

11. Kendrick S, Tus K, Wright G, Jaffe ES, Rosenwald A, Campo E, Chan WC, Connors JM,

Braziel RM, Ott G, Delabie J, Cook JR, Weisenburger DD, Greiner TC, Fu K, Staudt LM, Gascoyne RD, Scott DW, Rimsza LM Diffuse large B-cell lymphoma cell-of-origin classification using the Lymph2Cx assay in the context of BCL2 and MYC expression status Leuk Lymphoma. 2016;57:717-720

12. Keppler S, Weißbach S, Langer C, Knop S, Pischimarov J, Kull M, Stühmer T,

Steinbrunn T, Bargou R, Einsele H, Rosenwald A, Leich E Rare SNPs in receptor tyrosine kinase are negative outcome predictors in multiple myeloma Oncotarget. 2016;7:38762-38774

13. Koch K, Hoster E, Ziepert M, Unterhalt M, Ott G, Rosenwald A, Hansmann ML, Bernd

W, Stein H, Pöschel V, Dreyling M, Trümper L, Löffler M, Schmitz N, Hiddemann W, Pfreundschuh M, Klapper W

22

Publikationen Prof. Dr. A. Rosenwald

Clinical, pathological and genetic features of follicular lymphoma grade 3A – a joint analysis of the German low-grade and high-grade lymphoma study groups GLSG and DSHNHL Ann Oncol. 2016;27:1323-1329

14. Kordes M, Röring M, Heining C, Braun S, Hutter B, Richter D, Geörg C, Scholl C,

Gröschel S, Roth W, Rosenwald A, Geissinger E, von Kalle C, Jäger D, Brors B, Weichert W, Grüllich C, Glimm H, Brummer T, Fröhling S, Cooperation of BRAFF595L and mutant HRAS in histiocytic sarcoma provides new insights into oncogenic BRSF signaling Leukemia. 2016;30:937-946

15. Leich E, Hoster E, Wartenberg M, Unterhalt M, Siebert R, Koch K, Klapper W,

Engelhard M, Puppe B, Horn H, Staiger AM, Stuhlmann-Laeisz C, Bernd HW, Feller AC, Hummel M, Lenze D, Stein H, Hartmann S, Hansmann ML, Möller P, Hiddemann W, Dreyling M, Ott G, Rosenwald A; German Low Grade Lymphoma Study Group (GLSG) Similar clinical features in follicular lymphomas with and without breaks in the BCL2 locus Leukemia. 2016;30:854-860

16. Lorenz J, Waldschmidt J, Wider D, Follo M. Ihorst G, Chatterjee M, May AM, Duyster

J, Rosenwald A, Wasch R, Zirlik K, Engelhardt M From CLL to multiple myeloma – spleen tyrosine kinase (SYK) influences multiple myeloma cell survival and migration Br J Haematol. 2016;174:985-989

17. Mansouri L, Noerenberg D, Young E, Mylonas E, Abdulla M, Frick M, Asmar F,

Ljungström V, Schneider M, Yoshida K, Skaftason A, Pandzic T, Gonzalez B, Tasidou A, Waldhueter N, Rivas-Delgado A, Angelopoulou M, Ziepert M, Arends CM, Couronné L, Lenze D, Baldus CD, Bastard C, Okosun J, Fitzgibbon J, Dörken B, Drexler HG, Roos-Weil D, Schmitt CA, Munch-Petersen HD, Zenz T, Hansmann ML, Strefford JC, Enblad G, Bernard OA, Ralfkiaer E, Erlanson M, Korkolopoulou P, Hultdin M, Papadaki T, Grønbæk K, Lopez-Guillermo A, Ogawa S. Küppers R, Stamatopoulos K, Stavroyianni N, Kanellis G, Rosenwald A, Campo E, Amini RM, Ott G, Vassilakopoulos TP, Hummel M, Rosenquist R, Damm F Frequent NFKBIE deletions are associated with poor outcome in primary mediastinal B-cell lymphoma Blood. 2016;128:2666-2670

18. Otto C, Scholtysik R, Schmitz R, Kreuz M, Becher C, Hummel M, Rosenwald A,

Trümper L, Klapper W, Siebert R, Küppers R; for the „Molecular Mechanisms in Malignant Lymphomas“ Network Project Novel IGH and MYC translocation partners in diffuse large B cell lymphomas Genes Chromosomes Cancer. 2016;55:932-943

19. Rasche L, Ménoret E, Dubljevic V, Menu E, Vanderkerken K, Lapa C, Steinbrunn T,

Chatterjee M, Knop S, Duell J, Greenwood DL, Hensel F, Rosenwald A, Einsele H, Brändlein S

23

Publikationen Prof. Dr. A. Rosenwald

A GRP78-directed monoclonal antibody recaptures response in refractory multiple myeloma with extramedullary involvement Clin Cancer Res. 2016;22:4341-4349

20. Rauert-Wunderlich H, Rudelius M, Ott G, Rosenwald A

Targeting protein kinase C in mantle cell lymphoma Br J Haematol. 2016;173:394-403

21. Rauthe S, Rosenwald A

Lymphome des Mediastinums Pathologe. 2016;37:457-464

22. Rohr J, Guo S, Huo J, Bouska A, Lachel C, Li Y, Simon PD, Zhang W, Gong Q, Wang C,

Cannon A, Heavican T, Mottok A, Hung S, Rosenwald A, Gascoyne R, Fu K, Greiner TC, Weisenburger DD, Vose JM, Staudt LM, Xiao W, Borgstahl GE, Davis S, Steidl C, McKeithan T, Iqbal J, Chan WC Recurrent activating mutations of CD28 in peripheral T-cell lymphomas Leukemia. 2016;30:1062-1070

23. Rosenquist R, Rosenwald A, Du MQ, Gaidano G, Groenen P, Wotherspoon A, Ghia P,

Gaulard P, Campo E, Stamatopoulos K; European Research Initiative on CLL (ERIC) and the European Association for Haematopathology (EAHP) Clinical impact of recurrently mutated genes on lymphoma diagnostics: state-of-the art and beyond Haematologica. 2016; 101:1002-1009

24. Scarfò I, Pellegrino E, Mereu E, Kwee I, Agnelli L, Bergaggio E, Garaffo G, Vitale N,

Caputo M, Machiorlatti R, Circosta P, Abate F, Barreca A, Novero D, Mathew S, Rinaldi A, Tiacci E, Serra S, Deagli S, Neri A, Falini B, Rabadan R, Bertoni F, Inghirami G, Piva R; European T-Cell Lymphoma Study Group Collaborators: Boi M, Creszenzo R, Cuccuru G, Garaffo G, Gaudiano M, Inghirami G, Lasorsa E, Machiorlatti R, Medico E, Mereu E, Messana K, Pellegrino E, Piva R, Scarfò I, Spaccarotella E, Tabbò F, Todaro M, Barreca A, Fornari A, Novero D, Chilosi M, Zamò A, Facchetti F, Lonardi S, De Chiara A, Fulciniti F, Dogliano C, Ponzoni M, Agnelli L, Neri A, Todoerti K, Agostinelli C, Piccaluga PP, Pileri S, Falini B, Tiacci E, De Wolf-Peeters C, Tousseyn T, Van Loo P, Geissinger E, Müller-Hermelink HK, Rosenwald A, Matolscy A, Piris MA, Rodriguez-Pinilla ME, Bertoni F, Kwee I, Rinaldi A Identification of a new subclass of ALK-negative ALCL expressing aberrant levels of ERBB4 transcripts Blood. 2016;127:221-232

25. Schmidt J, Gong S, Marafioti T, Mankel B, Gonzalez-Farre B, Balagué O, Mozos A,

Cabeçadas J, van der Walt J, Hoehn D, Rosenwald A, Ott G, Dojcinov S, Egan C, Nadeu F, Ramis-Zaldivar JE, Clot G, Bárcena C, Pérez-Alonso V, Endris V, Penzel R, Lome-Maldonado C, Bonzheim I, Fend F, Campo E, Jaffe ES, Salverria I, Qunitanilla-Martinez Genome-wide analysis of pediatric-type follicular lymphoma reveals low genetic complexity and recurrent alterations of TNFRSF14 gene Blood. 2016;128:1101-1111

24

Publikationen Prof. Dr. A. Rosenwald

26. Schneider T, Strehl A, Linz C, Brands R, Hartmann S, Beckford F, Rosenwald A, Kübler

AC, Müller-Richter UD Phosphorylated epidermal growth factor receptor expression and KRAS mutation status in salivary gland carcinomas Clin Oral Invest. 2016;20:541-551

27. Shostak A, Ruppert B, Ha N, Bruns P, Toprak UH; ICGC MMML-Seq Project, Eils R,

Schlesner M, Diernfellner A, Brunner M Collaborators: Lawerenz C, Ruppert B, Radlwimmer B, … Rosenwald A, … , Sungalee S. Stadler PF, Zenz T MYC/MIZ1-dependent gene repression inversely coordinates the circadian clock with cell cycle and proliferation Nat. Comm. 2016;7: 11807

28. Yang Y, Kelly P, Shaffer AL 3rd, Schmitz R, Yoo HM, Liu X, Huang da W, Webster D, Young RM, Nakagawa M, Ceribelli M, Wright GW, Yang Y, Zhao H, Yu X, Xu W, Chan WC, Jaffe ES, Gascoyne RD, Campo E, Rosenwald A, Ott G, Delabie J, Rimsza L, Staudt Targeting non-proteolytic protein ubiquitination for the treatment of diffuse large B cell lymphoma Cancer Cell. 2016;29:494-507

2015

1. Abate F, Todaro M, van der Krogt JA, Boi M, Landra I, Machiorlatti R, Tabbò F, Messano J, Abele C, Barreca A, Novero D, Gaudiano M, Aliberti S, Di Giacomo F, Tousseyn T, Lasorsa E, Crescenzo R, Bessone L, Ficarra E, Acquaviva A, Rinaldi A, Ponzoni M, Longo DL, Aime S, Cheng M, Ruggeri B, Piccaluga PP, Pileri S, Tiacci E, Falini B, Pera-Gresely B, Cherchietti L, Iqbal J, Chan WC, Shultz LD, Kwee I, Piva R, Wlodorska I, Rabadan R, Bertoni F, Inghirami G; European T-cell Lymphoma Study Group. Collaborators: Abate F, Bessone L, Boi M, Cavallo F, Chiesa N., Crescenzo R, Fienga A, Gaudiano M, di Giacomo F, Inghirami G, Landra I, Lasorsa E, Marchioralatti R, Martinoglio B, Medico E, Ferrero GB, Messana K, Mereu E, Pellegrino E, Piva R, Scafò I, Spaccarotella E, Tabbò F, Todaro M, Ubezzi I, Urigu S, Novero D, Chiapella A, Vitolo U, Abate F, Ficarra E, Acquaviva A, Agnelli L, Neri A, Chilosi AC, Zamó A, Facchetti F, Lonardi S, De Chiara A, Fulciniti F, Ferreri A, Ponzoni M, Agostinelli C, Piccaluga PP, Pileri S, Falini B, Tiacci E, Van Loo P, Tousseyn T, De Wolf-Peeters C, Geissinger E, Müller-Hermelink HK, Rosenwald A, Piris MA, Rodriguez ME, Bertoni F, Rinaldi A, Kwee I, Chiattone C, Paes RA. A novel patient-derived tumorgraft model with TRAF1-ALK anaplastic large-cell lymphoma translocation Leukemia. 2015;29:1390-1401

2. Agaimy A, Wild V, Märkl B, Wachter DL, Hartmann A, Rosenwald A, Irler S.

25

Publikationen Prof. Dr. A. Rosenwald

Intraparotid classical and nodular lymphocyte predominant Hodgkin lymphoma: pattern analysis with emphasis on associated lymphadenoma-like proliferations Am J Surg Pathol. 2015;39:1206-1212

3. Brenner I, Roth S, Flossbach L, Wobser M, Rosenwald A, Geissinger E

Lack of MYD88 L265P mutation in primary cutaneous marginal zone lymphoma Br J Dermatol. 2015;173:1527-1528

4. Chopra M, Brandl A, Siegmund D, Mottok A, Schäfer V, Biehl M, Kraus S, Bäuerlein

CA, Ritz M, Mettenheimer K, Schwinn S, Seher A, Grabinger T, Einsele H, Rosenwald A, Brunner T, Beilhack A, Wajant H Blocking TWEAK-Fn14 interaction inhibits hematopoietic stem cell transplantation-induced intestinal cell death and reduces GvHD Blood. 2015;126;437-444

5. Creszenzo R, Abate F, Lasorsa E, Tabbo F, Gaudiano M, Chiesa N, Di Giacomo F,

Spaccarotella E, Barbarossa L, Ercole E, Todaro M, Boi M, Acquaviva A, Ficarra E, Novero D, Rinaldi A, Tousseyn T, Rosenwald A, Kenner L, Cerroni L, Tzankov A, Ponzoni M, Paulli M, Weisenburger D, Chan WC, Iqbal J, Piris MA, Zamo A, Ciardullo C, Rossi D, Gaidano G, Pileri S, Tiacci E, Falini B, Shultz LD, Mevellec L, Vialard JE, Piva R, Bertoni F, Rabadan R, Inghirami G; European T-Cell Lymphoma Study Group, T-Cell Project Prospective collection of data in patients with peripheral T-cell lymphoma and the AIRC 5xMille Consortium “Genetic-driven targeted management of lymphoid malignancies” Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma Cancer Cell. 2015;27:516-532 Erratum: Cancer Cell. 2015;27:744

6. Doose G, Haake A, Bernhart SH, López C, Duggimpudi S, Wojciech F, Bergmann AK,

Borkhardt A, Burkhardt B, Claviez A, Dimitrova L, Haas S, Hoell JI, Hummel M, Karsch D, Klapper W, Kleo K, Kretzmer H, Kreuz M, Küppers R, Lawerenz C, Lenze D, Loeffler M, Mantovani-Löffler L, Möller P, Ott G, Richter J, Rohde M, Rosenstiehl P, Rosenwald A, Schilhabel M, Schneider M, Scholz I, Stilgenbauer S, Stunnenberg HG, Szczepanowski M, Trümper L, Weniger MA; ICGC MMML-Seq Consortium, Hoffmann S, Siebert R, Iaccarino I MINCR is a MYC-induced IncRNA able to modulate MYCs transcriptional network in Burkitt lymphoma cells Proc Natl Acad Sci USA. 2015;112:E2561-2570

7. Horn H, Ziepert M, Wartenberg M, Staiger AM, Barth TF, Bernd HW, Feller AC,

Klapper W, Stuhlmann-Laeisz C, Hummel M, Stein H, Lenze D, Hartmann S, Hansmann ML, Möller P, Cogliatti S, Pfreundschuh M, Trümper L, Loeffler M, Glass B, Schmitz N, Ott G, Rosenwald A; DSHNHL 16 Different biological risk factors in young poor-prognosis and elderly patients with diffuse large B-cell lymphoma Leukemia. 2015;29:1564-1570

26

Publikationen Prof. Dr. A. Rosenwald

8. Horn H, Staiger AM, Vöhringer H, Hay U. Campo E, Rosenwald A, Ott G, Ott MM Diffuse large B-cell lymphomas of immunoblastic type are a major reservoir for MYC-IGH translocations Am J Surg Pathol. 2015;39:61-66

9. Iqbal J, Shen Y, Huang X, Liu Y, Wake L, Liu C, Deffenbacher K, Lachel CM, Wang C,

Rohr J, Guo S, Smith LM, Wright G, Bhagavati S, Dybkaer K, Fu K, Greiner TC, Vose JM, Jaffe E, Rimsza L, Rosenwald A, Ott G, Delabie J, Campo E, Braziel RM, Cook JR, Tubbs RR, Armitage JO, Weisenburger DD, Staudt LM, Gascoyne RD, McKeithan TW, Chan WC Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggressive B-cell lymphoma Blood. 2015;125:1137-1145

10. Kreft A, Springer E, Geissinger E, Wagner EM, Bender K, Kolbe K, Hainz M, Rosenwald

A, Herr W, Kirkpatrick CJ, Meyer RG Transmission of angioimmunoblastic T-cell lymphoma by bone marrow transplant Leuk Lymphoma. 2015;56:1164-1167

11. Lorenz J, Waldschmidt J, Wider D, Follo M, Ihorst G, Chatterjee M, May AM, Duyster

J, Rosenwald A, Wäsch R, Zirlik K, Engelhardt M From CLL to multiple myeloma – spleen tyrosine kinase (SYK) influences multiple myeloma cell survival and migration Br J Haematol. 2015 Oct 22 (epub ahead of print)

12. Momose S, Weißbach S, Pischimarov J, Nedeva T, Bach E, Rudelius M, Geissinger E,

Staiger AM, Ott G, Rosenwald A The diagnostic gray zone between Burkitt lymphoma and diffuse large B-cell lymphoma is also a gray zone of the mutational spectrum Leukemia. 2015;29:1789-1791

13. Pastore A, Jurinovic V, Kridel R, Hoster E, Staiger AM, Szczepanowski M, Pott C, Kopp

N, Murakami M, Horn H, Leich E, Moccia AA, Mottok A, Sunkavalli A, Van Hummelen P, Ducar M, Ennishi D, Shulha HP, Hother C, Connors JM, Sehn LH, Dreyling M, Neuberg D, Möller P, Feller AC, Hansmann ML, Stein H, Rosenwald A, Ott G, Klapper W, Unterhalt M, Hiddemann W, Gascoyne RD, Weinstock DM, Weigert O Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry Lancet Oncol. 2015;16:1111-1122

14. Philipp-Abbrederis K, Herrmann K, Knop S, Schottelius M, Eiber M, Lückerath K,

Pietschmann E, Habringer S, Gerngroß C, Franke K, Rudelius M, Schirbel A, Lapa C, Schwamborn K, Steidle S, Hartmann E, Rosenwald A, Kropf S, Beer AJ, Peschel C, Einsele H, Buck AK, Schwaiger M, Götze K, Wester HJ, Keller U In vivo molecular imaging of chemokine receptor CXCR4 expression in patients with advanced multiple myeloma EMBO Mol Med. 2015;7:477-487

27

Publikationen Prof. Dr. A. Rosenwald

15. Poppe H, Kerstan A, Böckers M, Goebeler M, Geissinger E, Rosenwald A, Hamm H

Childhood mycosis fungoides with a CD8+ cytotoxic immunophenotype J Cutan Pathol. 2015;42:258-264

16. Rasche L, Duell J, Castro IC, Dubljevic V, Chatterjee M, Knop S, Hensel F, Rosenwald

A, Einsele H, Topp MS, Brändlein S GRP78-directed immunotherapy in relapsed or refractory multiple myeloma – reults from a phase 1 trial with the monoclonal immunoglobulin M antibody PAT-SM6 Haematologica. 2015;100:377-384

17. Rudelius M, Rauert-Wunderlich H, Hartmann E, Hoster E, Dreyling M, Klapper W, Ott

G, Rosenwald A The G protein-coupled estrogen receptor 1 (GPER-1) contributes to the proliferation and survival of mantle cell lymphoma cells Haematologica. 2015;100:e458-461

18. Sbiera S, Leich E, Liebisch G, Sbiera I, Schirbel A, Wiemer L, Matysik S, Eckhardt C,

Gardill F, Gehl A, Kendl S, Weigand I, Bala M, Ronchi CL, Deutschbein T, Schmitz G, Rosenwald A, Allolio B, Fassnacht M, Kroiss M Mitotane inhibits Sterol-O-Acyl Transferase 1 triggering lipid-mediated endoplasmic reticulum stress and apoptosis in adrenocortical carcinoma cells Endocrinology. 2015;156:3895-3908

19. Staiger AM, Ott MM, Parmentier S, Rosenwald A, Ott G, Horn H, Griese EU

Allele-specific PCR is a powerful tool for the detection of the MYD88 L265P mutation in diffuse large B cell lymphoma and decalcified bone marrow samples B J Haematol. 2015;171:145-148

20. Vaeth M, Bäuerlein CA, Pusch T, Findeis J, Chopra M, Mottok A, Rosenwald A,

Beilhack A, Berberich-Siebelt F Selective NFAT targeting in T cells ameliorates GvHD while maintaining antitumor activity Proc Natl Acad Sci USA. 2015;112:1125-1130

21. Vasyutina E, Boucas JM, Bloehdorn J, Aszyk C, Crispatzu G, Stiefelhagen M, Breuer A,

Mayer P, Lengerke C, Döhner H, Beutner A, Rosenwald A, Stilgenbauer S, Hallek M, Benner A, Herling M The regulatory interaction of EVI1 with the TCL1A oncogene impacts cell survival and clinical outcome in CLL Leukemia. 2015;29:2003-2014

22. Von Eyss B, Jaenicke LA, Kortlever RM, Royla N, Wiese KE, Letschert S, McDuffus LA,

Sauer M, Rosenwald A, Evan GI, Kempa S, Eilers M A MYC-driven change in mitochondrial dynamics limits YAP/TAZ function in mammary epithelial cells and breast cancer Cancer Cell. 2015;28:743-757

28

Publikationen Prof. Dr. A. Rosenwald

23. Wagener R, Aukema S, Schlesner M, Haake A, Burkhardt B, Claviez A, Drexler HG, Hummel M, Kreuz M, Loeffler M, Rosolowski M, López C, Möller P, Richter J, Rohde M, Betts MJ, Russell RB, Bernhart SH, Hoffmann S, Rosenstiel P, Schilhabel M, Szczepanowski M, Trümper L, Klapper W, Siebert R; ICGC-MMML-Seq-Project; “Molecular Mechanisms in Malignant Lymphomas” Network Project of the Deutsche Krebshilfe Collaborators: Richter G, Siebert R, Wagner S, Haake A, Richter J, Eils R, Lawerenz C, Radomski S, Scholz I, Borst C, Burkhardt B, Claviez, A, Dreyling M, Eberth S, Einsele H, Frickhofen N, Haas S, Hansmann ML, Karsch D, Kneba M, Lisfeld J, Mantovani-Löffler L, Rohde M, Stadler C, Staib P., Stilgenbauer S, Ott G, Trümper L, Zenz T, Hansmann ML; Kube D, Küppers R, Weniger M, Haas S, Hummel M, Klapper W, Kostezka U, Lenze D, Möller P, Rosenwald A, Szczepanowski M, Ammerpohl O, Aukema SM, Binder V, Borkhardt A, Haake A, Hezaveh K, Hoell J, Leich E, Lichter P, Lopez C, Nagel I, Pischimarov J, Radlwimmer B, Richter J, Rosenstiel P, Rosenwald A, Schilhabel M, SchreiberS, Vater I, Wagner R, Siebert R, Bernhart SH, Binder H, Brors B, Doose G, Eils J, Eils R, Hoffmann S, Hopp L, Kretzmer H, Kreuz M, Korbel J, Langenberger D, Loeffler M, Radomski S, Rosolowski M, Schlesner M, Stadler PF, Sungalee S, Barth TF, Bernd HW, Cogliatti SB, Feller AC, Hansmann ML, Hummel M, Klapper W, Lenze D, Möller P., Müller-Hermelink HK, Ott G, Rosenwald A, Stein H, Szczepanowski M, Wacker HH, Barth TF, Behrmann P, Daniel P, Dierlamm J, Haralambieva E, Harder L, Holterhus PM, Küppers R, Kube D, Lichter P, Martin-Subero JI, Möller P, Murga-Peñas EM, Ott G, Pott C, Pscherer A, Rosenwald A, Schwaenen C, Siebert R, Trautmann H, Vockerodt M, Wessendorf S, Bentink S, Berger H, Hasenclever D, Kreuz M, Loeffler M, Rosolowski M, Spang R, Stürzenhofecker B, Trümper L, Wehner M, Loeffler M, Siebert R, Stein H, Trümper L The PCBP1 gene encoding poly(rC) binding protein I is recurrently mutated in Burkitt lymphoma Genes Chromosomes Cancer. 2015;54:555-564

24. Wang C, McKeithan TW, Gong Q, Zhang W, Bouska A, Rosenwald A, Gascoyne RD,

Wu X, Wang J, Muhammad Z, Jiang B, Rohr J, Cannon A, Steidl C, Fu K, Li Y, Hung S, Weisenburger DD, Greiner TC, Smith L, Ott G, Rogan EG, Staudt LM, Vose J, Iqbal J, Chan WC IDH2R172 mutations define a unique subgroup of patients with angioimmunoblastic T-cell lymphoma Blood. 2015;126:1741-1752

25. Weilemann A, Grau M, Erdmann T, Merkel O, Sobhiafshar U, Anagnostopoulos I,

Hummel M, Siegert A, Hayford C, Madle H, Wollert-Wulf B, Fichtner I, Dörken B, Dirnhofer S, Mathas S, Janz M, Emre NC, Rosenwald A, Ott G, Lenz P, Tzankov A, Lenz Essential role of IRF4 and MYC signaling for survival of anaplastic large cell lymphoma Blood. 2015;125:124-132

26. Weißbach S, Langer C, Puppe B, Nedeva T, Bach E, Kull M, Bargou R, Einsele H,

Rosenwald A, Knop S, Leich E The molecular spectrum and clinical impact of DIS3 mutations in multiple myeloma Br J Haematol. 2015;169:57-70

29

Publikationen Prof. Dr. A. Rosenwald

27. Wiegering A, Uhte FW, Jamieson T, Ruoss Y, Hüttenrauch M, Küspert M, Pfann C, Nixon C, Herold S, Walz S, Taranets L, Germer CT, Rosenwald A, Sansom OJ, Eilers M Targeting translation initiation bypasses signaling crosstalk mechanisms that maintain high MYC levels in colorectal cancer Cancer Discov. 2015;5:768-781

28. Wiese KE, Hakaila HM, von Eyss B, Wolff E, Esnault C, Rosenwald A , Treisman R,

Klefström J, Eilers M Repression of SRF target genes is critical for Myc-dependent apoptosis of epithelial cells EMBO J. 34:1554-1571

29. Wobser M, Roth S, Reinartz T, Rosenwald A, Goebeler M, Geissinger E

CD68 expression is a discriminative feature of indolent cutaneous CD8-positive lymphoid proliferation and distinguishes this lymphoma subtype from other CD8-positive cutaneous lymphomas Br J Dermatol. 2015:172:1573-1780

30. Young RM, Wu T, Schmitz R, Dawood M, Xiao W, Phelan JD, Xu W, Menard L, Meffre

E, Chan WC, Jaffe ES, Gascoyne RD, Campo E, Rosenwald A, Ott G, Delabie J, Rimsza LM, Staudt LM Survival of human lymphoma cells requires B-cell receptor engagement by self-antigens Proc Natl Acad Sci USA. 2015;112:13447-13454

31. Yuan J, Wright G, Rosenwald A, Steidl C, Gascoyne RD, Connors JM, Mottok A,

Weisenburger DD, Greiner TC, Fu K, Smith L, Rimsza LM, Jaffe ES, Campo E, Martinez A, Delabie J, Braziel RM, Cook JR, Ott G, Vose JM, Staudt LM, Chan WC; Lymphoma Leukemia Molecular Profiling Project (LLMPP) Identification of primary mediastinal large B-cell lymphoma at nonmediastinal sites by gene expression profiling Am J. Surg Pathol. 2015;39:1322-1330

Buchbeiträge

32. Jaffe ES, Gascoyne R, Nakamura S, Pileri SA, Rosenwald A (2015) B-cell lymphoma, unclassificable, with features internediate between diffuse large B-cell and classical Hodgkin lymphoma In: Travis WD et al (ed) WHO classification of tumours of the lung, pleura, thymus and heart. 4th ed. International Agency for Research on Cancer, Lyon, pp 280-281

33. Klapper W, Jaffe ES, Gaulard P, Harris NL, Gascoyne R, Möller P, Nakamura S,

Rosenwald A (2015) Primary mediastinal large B-cell lymphoma In: Travis WD et al (ed) WHO classification of tumours of the lung, pleura, thymus and heart. 4th ed. International Agency for Research on Cancer, Lyon, pp 267-269

30

Publikationen Prof. Dr. A. Rosenwald

34. Nakamura S, Jaffe ES, Harris NL, Rosenwald A (2015) Hodgkin lymphoma In: Travis WD et al (ed) WHO classification of tumours of the lung, pleura, thymus and heart. 4th ed. International Agency for Research on Cancer, Lyon, pp 277-279

35. Rosenwald A, Gascoyne R, Harris NL, Jaffe ES, Gaulard P (2015) Other mature B-cell

lymphomas In: Travis WD et al (ed) WHO classification of tumours of the lung, pleura, thymus and heart. 4th ed. International Agency for Research on Cancer, Lyon, p 272

2014

1. Achenbach M, Bittenbring JT, Ziepert M, Regitz E, Ott G, Rosenwald A, Pfreundschuh M, Altmann B, Held G Elevated serum free light chains do not predict outcome of elderly patients with aggressive CD20+ B-cell lymphomas Br J Haematol. 2014;167:430-434

2. Adler M, Leich E, Ellinger-Ziegelbauer H, Hewitt P, Dekant W, Rosenwald A, Mally A

Application of RNA interference to improve mechanistic understanding of omics responses to a hepatotoxic drug in primary rat hepatocytes Toxicology. 2014;326:86-95

3. Aukema SM, Kreuz M, Kohler CW, Rosolowski M, Hasenclever D, Hummel M, Küppers

R, Lenze D, Ott G, Pott C, Richter J, Rosenwald A, Szczepanowski M, Schwaenen C, Stein H, Trautmann H, Wessendorf S, Trümper L, Loeffler M, Spang R, Kluin PM, Klapper W, Siebert R; Molecular Mechanisms in Malignant Lymphoma Network Project Collaborators: Barth TF, Bernd HW, Cogliatti SB, Feller AC, Hansmann ML, Hummel M, Klapper W, Möller P, Müller-Hermelink HK, Oschlies I, Ott G, Rosenwald A, Stein H, Szczepanowski M, Barth TF, Daniel P, Dierlamm J, Gesk S, Haralambieva E, Harder L, Holterhus PM, Kube D, Lichter P, Martin-Subero JI, Möller P, Murga-Peñas EM, Pellissery S, Philipp C, Pott C, Pscherer A, Richter J. Rosenwald A, Salaverria I, Schwaenen C, Siebert R, Trautmann H, Vockerodt M, Wessendorf S, Bentik S, Berger H, Kohler CW, Hasenclever D, Kreuz M, Loeffler M, Rosolowski M, Spang R, Burkhardt B, Reiter A, Woessmann W, Stürzenhofecker B, Trümper L, Wehner M, Loeffler M, Siebert R, Stein H, Trümper L Biological characterization of adult MYC-translocation-postive mature B-cell lymphomas other than molecular Burkitt lymphoma Haematologica. 2014;99:726-735

4. Baumann U, Fernández-Sáiz V., Rudelius M, Lemeer S, Rad R, Knorn AM, Slawska J,

Engel K, Jeremias I, Li Z, Tomiatti V, Illert AL, Targosz BS, Braun M, Perner S, Leitges M, Klapper W, Dreyling M, Miething C, Lenz G, Rosenwald A, Peschel C, Keller U, Kusterm B, Bassermann E